CUV 0.67% $14.72 clinuvel pharmaceuticals limited

Ann: New case of SCENESSE efficacy in vitiligo presented at AAD, page-8

  1. 1,290 Posts.
    lightbulb Created with Sketch. 115
    Good news accompanied by record low sp, shorts love announcements!

    https://hotcopper.com.au/data/attachments/6023/6023440-86d76aa8bfda35c5c971e6cf121b1dc2.jpg
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.